Stock Price Quote

SANOFI INDIA LTD.

NSE : SANOFIBSE : 500674ISIN CODE : INE058A01010Industry : Pharmaceuticals & DrugsHouse : Sanofi India - MNC
BSE6895.70110.5 (+1.63 %)
PREV CLOSE ( ) 6785.20
OPEN PRICE ( ) 6783.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 978
TODAY'S LOW / HIGH ( )6783.00 6990.00
52 WK LOW / HIGH ( )5850.55 10526.05
NSE6901.25116.9 (+1.72 %)
PREV CLOSE( ) 6784.35
OPEN PRICE ( ) 6804.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 6901.25 (13)
VOLUME 13535
TODAY'S LOW / HIGH( ) 6804.95 6990.90
52 WK LOW / HIGH ( )5892.8 10524.95
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 02-05 1956
Management Info
Aditya Narayan - Chairman Rodolfo Hrosz - Managing Director
Registered Office

Address Sanofi House, C T S No. 117- B,L & T Business Park,Saki Vihar Road, Powai,
Mumbai,
Maharashtra-400072

Phone 022-2803 2000

Email igrc.sil@sanofi.com

Website www.sanofiindialtd.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX

NEWS

01Aug Sanofi India informs about details of
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure..
24Jun Sanofi India informs about change in m
In furtherance of communication dated 1st June 2024 under Regulation 30..
27Mar Sanofi India enters into partnership w
Sanofi India (SIL) and Sanofi Healthcare India (together referred as ‘Sa..
27Mar Sanofi India shines on entering into p
Sanofi India is currently trading at Rs. 8049.00, up by 338.15 points or..
12Mar Sanofi India informs about loss of sha
Sanofi India has informed that the Company has received communication fr..

Financials

in Millions
QTR Jun 24 ANNUAL 23
Net Profit10346032
Gross Profit 921 8458
Operating Profit 12058693
Net Sales 463528511

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Divi's Lab (BSE)
peergroup  5987.25 (7.94%)
M.Cap ( in Cr)158942.68
Hester Biosciences (BSE)
peergroup  2379.75 (5.25%)
M.Cap ( in Cr)2024.42
Glaxosmithkline Phar (BSE)
peergroup  2811.75 (3.79%)
M.Cap ( in Cr)47632.74
Astrazeneca Pharma I (BSE)
peergroup  7864.35 (1.28%)
M.Cap ( in Cr)19660.88
Neuland Laboratories (BSE)
peergroup  11799.70 (0.77%)
M.Cap ( in Cr)15138.88

Shareholding Pattern

PROMOTERS 60.4%
MUTUAL FUNDS/UTI 11.59%
NON-INSTITUTION 11.2%
FI/BANKS/INSURANCE 10.94%
GOVERNMENT 0%
FII 0%

About Sanofi India Ltd.

Sanofi India Ltd. was incorporated in the year 1956. Its today's share price is 6895.7. Its current market capitalisation stands at Rs 15881.23 Cr. In the latest quarter, company has reported Gross Sales of Rs. 29642 Cr and Total Income of Rs.29176 Cr. The company's management includes Renee Amonkar, Rachid Ayari, Radhika Shah, Rodolfo Hrosz, Vaibhav Karandikar, Rahul Bhatnagar, Usha Thorat, Aditya Narayan.

It is listed on the BSE with a BSE Code of 500674 , NSE with an NSE Symbol of SANOFI and ISIN of INE058A01010. It's Registered office is at Sanofi House, C T S No. 117- B,L & T Business Park,Saki Vihar Road, PowaiMumbai-400072, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are PC Hansotia & Co, Price Waterhouse & Co, Price Waterhouse & Co Chartered Accountants LLP, SR Batliboi & Co, SR Batliboi & Co LLP, SRBC & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.